Evolution of Healing via SkinTE®

SkinTE is an investigational, autologous heterogeneous skin construct designed to initiate the wound healing process by providing healthy cells and chemokines in the wound bed. Following application, multicellular segments may engraft and serve as a cellular source within the wound bed. In clinical studies, SkinTE has demonstrated the ability to initiate cellular activity associated with tissue repair.

Explore PolarityBio’s Science, Pipeline, and Clinical Development

Blue circular icon with white lines and dots representing networking or connectivity.

Learn about the scientific basis for SkinTE®, an investigational autologous multicellular skin therapy being studied for chronic wound healing and diabetic foot ulcers.

The Science of SkinTE

Flag with a checkmark on it inside a blue circle.

Browse peer-reviewed publications and clinical research related to SkinTE® and chronic wound healing, including current investigational development and legacy scientific context.

Publications & Clinical Research

Neon blue circular sign with a white outline of a cowboy boot.

Explore PolarityBio’s development pipeline, featuring SkinTE® in Phase III clinical development for Wagner Grade 1 diabetic foot ulcers and future regenerative biologic programs.

Development Pipeline

Understand the FDA-cleared Expanded Access Program that provides eligible patients with investigational access to SkinTE®.

Expanded Access Program

Company News and Leadership

Icon of a paper document on a blue circular background.

Contact Us

PolarityTE Headquarters
1960 South 4250 West
Salt Lake City, UT 84104

Investor Relations
Parker Scott
IR@polaritybio.com

Call Us
Corporate Main: 800-560-3983

SkinTE is an investigational product and has not been approved or cleared by the U.S. Food and Drug Administration. Availability is limited to participation in clinical studies or under an Expanded Access Program.

All medical products carry potential risks. Safety data for SkinTE are being collected in ongoing clinical studies.

The information provided on this website is intended for educational and informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Statements on this site regarding investigational products are based on clinical research and have not been evaluated or approved by the U.S. Food and Drug Administration. Individual outcomes may vary.

This website may contain forward-looking statements regarding PolarityBIO’s research programs, product candidates, and clinical development plans. These statements are based on current expectations and are subject to risks and uncertainties that could cause actual results to differ materially. PolarityBIO undertakes no obligation to update such statements.

The information on this website is intended for residents of the United States and may not apply to other countries.